XML 60 R46.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair Value of Financial Instruments (Tables)
 12 Months Ended
Dec. 29, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
As of December 29, 2024 and December 31, 2023, the Company had the following assets and liabilities measured at fair value in its Consolidated Balance Sheets (excluding assets for which the fair value is measured using net asset value per share):
Fair Value Measurements Using
(In millions)Fair
Value		Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)
December 29, 2024
Assets:
Available-for-sale securities$0.6 $0.6 $— $— 
Derivatives9.7 — 9.7 — 
Total assets$10.3 $0.6 $9.7 $— 
Liabilities:
Derivatives$1.7 $— $1.7 $— 
Total liabilities$1.7 $— $1.7 $— 
December 31, 2023
Assets:
Available-for-sale securities$1.1 $1.1 $— $— 
Derivatives0.7 — 0.7 — 
Total assets$1.8 $1.1 $0.7 $— 
Liabilities:
Derivatives$3.9 $— $3.9 $— 
Option agreement1.7 — — 1.7 
Total liabilities$5.6 $— $3.9 $1.7